Citigroup Cuts Amrize (NYSE:AMRZ) Price Target to $58.00

Amrize (NYSE:AMRZ) had its price objective dropped by equities researchers at Citigroup from $66.00 to $58.00 in a report released on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 21.85% from the company’s previous close.

A number of other analysts also recently commented on AMRZ. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a report on Friday, June 26th. Stephens reaffirmed an “overweight” rating and issued a $65.00 price objective on shares of Amrize in a research note on Monday, May 18th. Wells Fargo & Company reduced their price objective on Amrize from $65.00 to $58.00 and set an “overweight” rating for the company in a report on Wednesday, July 8th. Oppenheimer decreased their target price on Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 21st. Finally, Royal Bank Of Canada lowered Amrize from a “sector perform” rating to an “underperform” rating and lowered their target price for the company from $60.00 to $48.00 in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $61.36.

Amrize Price Performance

NYSE:AMRZ traded up $1.31 during trading hours on Tuesday, hitting $47.60. The company’s stock had a trading volume of 3,491,854 shares, compared to its average volume of 3,206,509. Amrize has a 52-week low of $46.03 and a 52-week high of $65.94. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. The business’s 50-day moving average is $51.79 and its two-hundred day moving average is $54.68. The company has a market capitalization of $26.33 billion, a PE ratio of 21.95, a PEG ratio of 0.98 and a beta of 0.12.

Amrize (NYSE:AMRZ) last issued its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a return on equity of 10.17% and a net margin of 9.89%.The company had revenue of $3.50 billion for the quarter. As a group, research analysts anticipate that Amrize will post 2.76 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Nollaig Forrest bought 2,000 shares of the company’s stock in a transaction dated Friday, May 22nd. The stock was acquired at an average cost of $50.25 per share, with a total value of $100,500.00. Following the acquisition, the insider owned 20,139 shares in the company, valued at approximately $1,011,984.75. This represents a 11.03% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Mario Gross purchased 2,800 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The shares were acquired at an average cost of $49.17 per share, with a total value of $137,676.00. Following the completion of the acquisition, the insider directly owned 33,747 shares in the company, valued at approximately $1,659,339.99. This represents a 9.05% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders acquired 54,918 shares of company stock worth $2,717,324. Insiders own 0.54% of the company’s stock.

Institutional Trading of Amrize

A number of institutional investors have recently bought and sold shares of the business. MCF Advisors LLC bought a new position in shares of Amrize during the 4th quarter valued at about $27,000. Basepoint Wealth LLC bought a new stake in Amrize during the fourth quarter worth about $33,000. Laurel Wealth Advisors LLC acquired a new position in Amrize during the fourth quarter worth $34,000. US Bancorp DE acquired a new stake in Amrize in the third quarter valued at $38,000. Finally, Itau Unibanco Holding S.A. lifted its stake in Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after acquiring an additional 450 shares during the last quarter.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.